Metraipolis › archive › dc_613daf6b4fe5

Individualizing isotretinoin dosing in acne: comparable 24-week efficacy and better tolerability at lower daily doses — Europe PMC PMID:41877774

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41877774
DOI
10.3389/fmed.2026.1771320
License (as archived)
solo-consultazione
Archived
2026-11-05T00:28:57.761Z
SHA-256 of the archived text
a891d3365ba6dff7e9850da11c3820d2c9e22712193cd0859f5269652e81926e
Stable URL of this page
https://metraipolis.com/documento/dc_613daf6b4fe5

How to cite

Individualizing isotretinoin dosing in acne: comparable 24-week efficacy and better tolerability at lower daily doses — Europe PMC PMID:41877774 — Europe PMC (en), https://europepmc.org/article/MED/41877774 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_613daf6b4fe5 (Metraipolis archive dc_613daf6b4fe5, sha256 a891d3365ba6dff7e9850da11c3820d2c9e22712193cd0859f5269652e81926e)
BibTeX
@misc{dc613daf6b4fe5,
  title = {Individualizing isotretinoin dosing in acne: comparable 24-week efficacy and better tolerability at lower daily doses — Europe PMC PMID:41877774},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41877774},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_613daf6b4fe5; sha256 a891d3365ba6dff7e9850da11c3820d2c9e22712193cd0859f5269652e81926e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41877774. Agents can read the archived copy with the MCP tool read_document.